英和和英

出典:『Wikipedia』 (2010/12/12 22:01 UTC 版)

英語による解説

引用

BioLogue is a Danish Copenhagen-based Public-Private Partnership operating within the field of life sciences: biomedical research, medicines development, education and training; science collaborations and Public-Private Partnership strategy. BioLogue is anchored in academia with support from and outreach to participating hospitals, the Danish Medicines Agency, pharma and biotech industry and other relevant organisations. Member companies are from the heart of Medicon Valley and include Novo Nordisk, H. Lundbeck, Nycomed, TopoTarget, Ferring Pharmaceuticals, Capio-Unilabs, Bio-Rad and many more. The consortium provides a neutral platform for students, researchers and professionals to meet and collaborate on research themes of mutual interest. BioLogue's focus areas include translational research, biomarkers, imaging, clinical research and biobanks. The overall aim of activities is to facilitate the development of novel medicines and related health care products, and to make them available to patients. The consortium is integrated with the university collaboration, Danish Pharma Consortium, and it has activities at both national and international levels, e.g. International Science Partnering Missions (e.g. Israel, United Kingdom, The Netherlands, USA) and European Technology Platform Initiatives. BioLogue was founded in 2005, and it is hosted by University of Copenhagen.